Common aspirin tested to halt growth of rare ear tumors
NCT ID NCT03079999
Summary
This study is testing whether taking aspirin daily can slow or stop the growth of vestibular schwannomas, which are non-cancerous tumors affecting hearing and balance nerves. About 97 patients aged 12 and older will be randomly assigned to take either aspirin or a placebo pill for up to 42 months. The main goal is to see if aspirin can delay tumor growth by more than 20% and help preserve hearing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR SCHWANNOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Stanford Otolaryngology/HNS
Stanford, California, 94304, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Utah
Salt Lake City, Utah, 84101, United States
Conditions
Explore the condition pages connected to this study.